Published in J Neurooncol on March 23, 2010
Tanshinone IIA and astragaloside IV promote the migration of mesenchymal stem cells by up-regulation of CXCR4. Protoplasma (2012) 0.90
Hypoxia impedes vasculogenesis of in vitro engineered bone. Tissue Eng Part A (2011) 0.79
Emerging Targets in Pituitary Adenomas: Role of the CXCL12/CXCR4-R7 System. Int J Endocrinol (2014) 0.75
Pituitary Adenoma and the Chemokine Network: A Systemic View. Front Endocrinol (Lausanne) (2015) 0.75
Pituitary apoplexy: its incidence and clinical significance. J Neurosurg (1981) 2.65
Tyrosine phosphorylation of caveolin-1 in the endothelium. Exp Cell Res (1999) 1.89
Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J Cell Biol (2001) 1.67
Isoforms of caveolin-1 and caveolar structure. J Cell Sci (2000) 1.65
A helical polymer with a cooperative response to chiral information. Science (1995) 1.56
Focal macular ERGs in eyes after removal of macular ILM during macular hole surgery. Invest Ophthalmol Vis Sci (2001) 1.55
Spontaneous regression of a germinoma in the pineal body after placement of a ventriculoperitoneal shunt. J Neurosurg (2000) 1.48
A case of pleomorphic xanthoastrocytoma presenting with massive tumoral hemorrhage. J Neurooncol (2005) 1.45
Clinical and cytofunctional classification of pituitary adenomas: proposal of a new classification. Acta Neurochir (Wien) (1996) 1.38
Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol (2009) 1.37
Molecular characterization of Streptococcus mutans strains containing the cnm gene encoding a collagen-binding adhesin. Arch Oral Biol (2009) 1.06
Comparison of inflammatory changes caused by Porphyromonas gingivalis with distinct fimA genotypes in a mouse abscess model. Oral Microbiol Immunol (2004) 1.02
Preoperative embolization of meningiomas with N-butyl cyanoacrylate. Interv Neuroradiol (2012) 1.00
The c-Jun NH2-terminal kinase3 (JNK3) gene: genomic structure, chromosomal assignment, and loss of expression in brain tumors. J Hum Genet (2001) 0.99
Magnetic resonance imaging-documented extravasation as an indicator of acute hypertensive intracerebral hemorrhage. J Neurosurg (1998) 0.99
Distribution of Porphyromonas gingivalis fimA genotypes in cardiovascular specimens from Japanese patients. Oral Microbiol Immunol (2008) 0.98
Modification of the superfluid 3He phase diagram by impurity scattering. Phys Rev Lett (2001) 0.97
Heterogenic virulence and related factors among clinical isolates of Porphyromonas gingivalis with type II fimbriae. Oral Microbiol Immunol (2008) 0.97
Lectin-binding sites of the human pituitary adenoma cells by means of the ferritin-labeling technique. Acta Neuropathol (1982) 0.96
Blue-on-yellow perimetry in the complete type of congenital stationary night blindness. Invest Ophthalmol Vis Sci (1999) 0.94
Three-dimensional computerized tomography angiography in patients with hyperacute intracerebral hemorrhage. J Neurosurg (1999) 0.94
Petrous apex cholesterol granuloma treated via the endoscopic transsphenoidal approach. Acta Neurochir (Wien) (2007) 0.92
Prions prevent brain damage after experimental brain injury: a preliminary report. Acta Neurochir Suppl (2003) 0.92
Cavernous hemangioma of the skull in a neonate. Childs Nerv Syst (1999) 0.91
Detection and serotype distribution of Actinobacillus actinomycetemcomitans in cardiovascular specimens from Japanese patients. Oral Microbiol Immunol (2007) 0.91
A simple device to prevent back flow of blood into the intravenous line. Anesthesiology (1998) 0.91
Emergence of immunoreactivities for phosphorylated tau and amyloid-beta protein in chronic stage of fluid percussion injury in rat brain. Neuroreport (1998) 0.90
Displacement of the double-lumen endobronchial tube can be detected by bronchial cuff pressure change. Anesth Analg (1997) 0.90
Efficacy and safety of growth hormone (GH) in the treatment of adult Japanese patients with GH deficiency: a randomised, placebo-controlled study. Growth Horm IGF Res (2006) 0.90
Caveolae: from a morphological point of view. J Electron Microsc (Tokyo) (1998) 0.89
Protein antigen in serotype k Streptococcus mutans clinical isolates. J Dent Res (2008) 0.87
Anterior vertebral artery decompression with an ultrasonic bone curette to treat bow hunter's syndrome. Acta Neurochir (Wien) (2008) 0.87
Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas. Clin Endocrinol (Oxf) (2001) 0.87
[Cerebral blood flow (CBF) before and after cranioplasty performed during the chronic stage after decompressive craniectomy evaluated by xenon-enhanced computerized tomography (Xe-CT) CBF scanning]. No Shinkei Geka (1999) 0.86
Signalling pathway mediated by CXCR7, an alternative chemokine receptor for stromal-cell derived factor-1α, in AtT20 mouse adrenocorticotrophic hormone-secreting pituitary adenoma cells. J Neuroendocrinol (2009) 0.86
Demonstration of mother-to-child transmission of Streptococcus mutans using multilocus sequence typing. Caries Res (2008) 0.86
Spontaneous intraventricular hemorrhage caused by lateral ventricular meningioma--case report. Neurol Med Chir (Tokyo) (1996) 0.86
Interleukin-18 mRNA expression in the rat pituitary gland. J Neuroimmunol (2006) 0.86
Cariogenicity of the probiotic bacterium Lactobacillus salivarius in rats. Caries Res (2005) 0.86
Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Mod Pathol (2001) 0.85
Exogenous expression of Pit-1 in AtT-20 corticotropic cells induces endogenous growth hormone gene transcription. J Endocrinol (2002) 0.84
Pituitary stone--case report. Neurol Med Chir (Tokyo) (2000) 0.84
Mutations of the MEN1 tumor suppressor gene in sporadic pituitary tumors. Cancer Lett (1999) 0.84
A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease. Oral Dis (2014) 0.84
Detection of serotype k Streptococcus mutans in Thai subjects. Oral Microbiol Immunol (2009) 0.83
Hemangioblastomas with blood supply from the dural arteries--two case reports. Neurol Med Chir (Tokyo) (2000) 0.83
Distribution of periodontopathic bacterial species in dogs and their owners. Arch Oral Biol (2012) 0.82
GH and PRL gene expression by nonradioisotopic in situ hybridization in TSH-secreting pituitary adenomas. J Clin Endocrinol Metab (1995) 0.82
Hyperprolactinemia in Cushing's disease and Nelson's syndrome. J Clin Endocrinol Metab (1984) 0.82
[Occipital neuralgia caused by the compression of the fenestrated vertebral artery: a case report]. No Shinkei Geka (1999) 0.82
Contribution of cell surface protein antigen c of Streptococcus mutans to platelet aggregation. Oral Microbiol Immunol (2009) 0.82
Management of huge pituitary adenomas. Acta Neurochir Suppl (1996) 0.82
Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study Group of 20K hGH. J Clin Endocrinol Metab (1999) 0.82
Molecular analysis of aortic intimal hyperplasia caused by Porphyromonas gingivalis infection in mice with endothelial damage. J Periodontal Res (2009) 0.82
Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy. Mod Pathol (1998) 0.81
Thyrotropin-secreting pituitary adenomas. Clinical and biological heterogeneity and current treatment. J Neurooncol (2001) 0.81
Secretion of glycoprotein hormone alpha-subunit by pituitary tumors. J Clin Endocrinol Metab (1987) 0.81
Frequent allelic loss at the TOC locus on 17q25.1 in primary breast cancers. Genes Chromosomes Cancer (1999) 0.81
The efficacy of radiotherapy for craniopharyngioma. J Neurosurg (1985) 0.81
Characterization of aortic aneurysms in cardiovascular disease patients harboring Porphyromonas gingivalis. Oral Dis (2010) 0.80
GHRH activates a nonselective cation current in human GH-secreting adenoma cells. Am J Physiol (1996) 0.80
A case of pituitary somatotroph adenoma with concomitant secretion of growth hormone, prolactin, and adrenocorticotropic hormone--an adenoma derived from primordial stem cell, studied by immunohistochemistry, in situ hybridization, and cell culture. Acta Neurochir (Wien) (1996) 0.80
Ruptured aneurysm of the orbitofrontal artery associated with dural arteriovenous malformation in the anterior cranial fossa--case report. Neurol Med Chir (Tokyo) (1999) 0.80
Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas. Mod Pathol (2001) 0.80
Gi3 mediates somatostatin-induced activation of an inwardly rectifying K+ current in human growth hormone-secreting adenoma cells. Endocrinology (1997) 0.80
Use of diffusion-weighted magnetic resonance imaging in empyema after cranioplasty. Br J Neurosurg (2004) 0.80
Intracranial malignant meningioma with abdominal metastases associated with hypoglycemic shock: a case report. J Neurooncol (2000) 0.80
Expression of plurihormonal mRNAs in somatotrophic adenomas detected using a nonisotopic in situ hybridization method: comparison with lactotrophic adenomas. Hum Pathol (1995) 0.80
Different mutation of the XLRS1 gene causes juvenile retinoschisis with retinal white flecks. Br J Ophthalmol (2001) 0.80
Effects of activin A and somatostatin on intact FSH secretion and intracellular Ca2+ concentration in human FSH-secreting pituitary adenoma cells. Biochem Biophys Res Commun (1992) 0.79
Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Mod Pathol (1994) 0.79
In vitro inhibition of cell proliferation, viability, and invasiveness in U87MG human glioblastoma cells by estramustine phosphate. Neurosurgery (1996) 0.79
[Clinicopathological studies of craniocerebral gunshot injuries]. No Shinkei Geka (1997) 0.79
Defect of glucosyltransferases reduces platelet aggregation activity of Streptococcus mutans: analysis of clinical strains isolated from oral cavities. Arch Oral Biol (2010) 0.79
Expression of Ptx1 in the adult rat pituitary glands and pituitary cell lines: hormone-secreting cells and folliculo-stellate cells. Cell Tissue Res (1999) 0.79
[Use of fluid-attenuated inversion recovery (FLAIR) images in brain check-up]. No To Shinkei (1999) 0.79
Growth hormone-releasing hormone expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system. Hum Pathol (2000) 0.79
Inactivation of the tumor suppressor gene on 11q13 in brothers with familial acrogigantism without multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (1997) 0.79
Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas. Neuroendocrinology (1997) 0.79
Drug-induced apoptosis by anti-microtubule agent, estramustine phosphate on human malignant glioma cell line, U87MG; in vitro study. J Neurooncol (2000) 0.79
Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Growth Horm IGF Res (2008) 0.79
[A case of neurocysticercosis presenting as focal seizure]. No Shinkei Geka (2000) 0.79
Effect of hypercapnia on arterial hypotension after induction of anaesthesia. Acta Anaesthesiol Scand (2005) 0.79
Three-dimensional CT angiography of intracranial vasospasm following subarachnoid haemorrhage. Neuroradiology (1998) 0.79
A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly. J Clin Endocrinol Metab (1997) 0.79
Gigantism in sibling unrelated to multiple endocrine neoplasia: case report. Neurosurgery (1994) 0.79
Malignant fibrous histiocytoma in the parietal bone. Neurol Med Chir (Tokyo) (1998) 0.79
Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas. Endocr Pathol (2001) 0.78
Solvent effects on the cooperative order-disorder transition of aqueous solutions of schizophyllan, a triple-helical polysaccharide. Biopolymers (1990) 0.78
Microcapsulated parathyroid tissue in vitro. Biomed Pharmacother (2000) 0.78
Expression of human Pit-1 product in the human pituitary and pituitary adenomas. Immunohistochemical studies using an antibody against synthetic human Pit-1 product. Arch Pathol Lab Med (1996) 0.78
Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage? Pituitary (1999) 0.78
Correlation of biological properties with glucan-binding protein B expression profile in Streptococcus mutans clinical isolates. Arch Oral Biol (2010) 0.78
[Immunohistochemical observations of the pituitary adenomas with the use of enzyme labeled antibody method--on the cases with hyperprolactinemia (author's transl)]. Neurol Med Chir (Tokyo) (1978) 0.78
Mechanisms of action of somatostatin on human TSH-secreting adenoma cells. Am J Physiol (1995) 0.78
The usefulness of bone metabolic indices for the prediction of changes in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism. Horm Metab Res (2006) 0.78
Suppression of matrix metalloproteinase-2 and -9 mediated invasiveness by a novel matrix metalloproteinase inhibitor, BE16627B. J Neurooncol (2001) 0.78
In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas. Acta Neuropathol (1996) 0.78
Corticotropin-releasing hormone excites adrenocorticotropin-secreting human pituitary adenoma cells by activating a nonselective cation current. J Clin Invest (1996) 0.78